May Matthias, Spachmann Philipp J, Lebentrau Steffen, Schumacher Harald, Gilfrich Christian, Fritsche Hans-Martin, Vetterlein Malte, Brookman-May Sabine, Schostak Martin, Wagenlehner Florian M, Burger Maximilian, Novotny Alexander, Obermaier Robert
Urologische Klinik, St. Elisabeth-Klinikum Straubing, Deutschland.
Urologische Klinik, Universität Regensburg, Caritas-Krankenhaus St. Josef, Regensburg, Deutschland.
Zentralbl Chir. 2017 Jun;142(3):297-305. doi: 10.1055/s-0042-120546. Epub 2017 Jun 22.
At the present time, there is no evidence available as to the knowledge of general surgeons regarding multi-resistant pathogens (MRP) and the rational use of antibiotic medication (antibiotic stewardship/ABS) compared with physicians from other disciplines. As part of the MR2 survey (Multiinstitutional Reconnaissance of practice with MultiResistant bacteria - a survey focussing on German hospitals), a questionnaire comprising 4 + 35 items was distributed to urologists, internists, gynaecologists and general surgeons in 18 hospitals. Multivariate regression models were applied to assess the impact of each discipline affiliation on predefined endpoints. 456 evaluable surveys were analysed. The response rate of surgeons (156/330; 47%) and physicians from other disciplines (300/731; 41%) did not differ significantly. Based on their self-assessment, surgeons indicated a significantly lower certainty regarding the correct choice of dose, frequency and duration of antibiotic treatment (p = 0.005), the decision between intravenous or oral application (p = 0.005), as well as the accurate interpretation of microbiological reports (p = 0.023). Both surgeons and doctors from other disciplines rated their knowledge of ABS as limited. An insignificant difference was found between surgeons and non-surgeons regarding the knowledge of E. coli resistance against Ciprofloxacin in their own hospital (27.6 vs. 35.3% estimated the correct category; p = 0.114), with 64% of surgeons underestimating the local resistance rates. Both physician groups assumed that the frequent use of broad-spectrum antibiotics is substantially responsible for the increase in MRP. However, in the given case study of a highly symptomatic female patient with uncomplicated urinary tract infection, both physician groups were almost equally likely to propose treatment with a broad-spectrum antibiotic (34.0 vs. 29.3%; p = 0.331). Based on the results of the multivariate models, there were no significant differences between surgeons and non-surgeons with regard to both the attendance of training courses related to MRP/ABS over the past 12 months and the quality of discharge summaries in their hospitals regarding the correct listing of MRP. In due consideration of the results of the MR2 survey, mandatory ABS programs should be implemented in hospitals, including regular training of physicians regardless of their discipline.
目前,尚无证据表明普通外科医生与其他学科的医生相比,对多重耐药病原体(MRP)的了解以及对抗生素药物的合理使用(抗生素管理/ABS)情况如何。作为MR2调查(多重耐药菌实践的多机构调研——一项聚焦于德国医院的调查)的一部分,一份包含4 + 35项内容的问卷被分发给18家医院的泌尿科医生、内科医生、妇科医生和普通外科医生。应用多变量回归模型来评估各学科归属对预定义终点的影响。对456份可评估的调查问卷进行了分析。外科医生(156/330;47%)和其他学科医生(300/731;41%)的回复率没有显著差异。根据自我评估,外科医生表示在抗生素治疗剂量、频率和疗程的正确选择(p = 0.005)、静脉或口服给药方式的决定(p = 0.005)以及微生物学报告的准确解读(p = 0.023)方面,确定性明显较低。外科医生和其他学科医生都认为他们对ABS的了解有限。在对自己医院中大肠杆菌对环丙沙星的耐药性了解方面,外科医生和非外科医生之间没有发现显著差异(分别估计正确类别的比例为27.6%和35.3%;p = 0.114),64%的外科医生低估了当地的耐药率。两个医生群体都认为广谱抗生素的频繁使用是MRP增加的主要原因。然而,在给定的一例有高度症状但无并发症尿路感染的女性患者的案例研究中,两个医生群体几乎同样有可能建议使用广谱抗生素进行治疗(34.0%对29.3%;p = 0.331)。根据多变量模型的结果,在过去12个月中参加与MRP/ABS相关培训课程的情况以及医院出院小结中关于MRP正确列出的质量方面,外科医生和非外科医生之间没有显著差异。考虑到MR2调查的结果,医院应实施强制性的ABS计划,包括对所有学科的医生进行定期培训。